Clinical Genetics

Understanding the Genetics and Diagnosis of Pitt-Hopkins Syndrome

At a Glance

Pitt-Hopkins syndrome is caused by a disease-causing change or deletion in one copy of the TCF4 gene. Genetic testing confirms the diagnosis, while characteristic facial features and awake hyperventilation followed by apnea can provide important clues.

Being told your child has a rare condition like Pitt-Hopkins Syndrome (PTHS) can feel overwhelming and isolating. Because it is a rare disorder, many healthcare providers may never have seen it before, often leading to a long “diagnostic odyssey” ^[1]^[2]. While it is rare, PTHS is likely underdiagnosed because its symptoms overlap with more common conditions ^[3]^[4]. Understanding the genetics and the specific “look” of PTHS is the first step in moving from the search for answers to a focused plan for your child’s care.

The Role of the TCF4 Gene

Pitt-Hopkins Syndrome is caused by a problem with the TCF4 gene, located on chromosome 18 (at a specific spot called 18q21.2) ^[5]. This gene provides instructions for making a protein that acts as a “master switch” (a transcription factor), turning other genes on and off during brain development ^[6].

For the brain to develop and function normally, your child needs two working copies of the TCF4 gene. PTHS occurs when one copy is missing or broken—a state called haploinsufficiency ^[6]. This can happen in three main ways:

Deletions: A piece of chromosome 18 is missing, taking the TCF4 gene with it ^[2].
Mutations: A “spelling error” within the gene (like a nonsense or frameshift mutation) makes the protein short and non-functional ^[6].
Missense Variants: A single letter change in the genetic code that alters the protein’s shape. Only pathogenic or likely pathogenic variants are diagnostic; a Variant of Uncertain Significance (VUS) does not establish the diagnosis ^[7].

Recognizing the Facial “Gestalt”

Doctors use the word gestalt to describe a “whole picture” or a recognizable pattern of features that, when seen together, suggest a specific diagnosis ^[8]. In PTHS, these features often become more distinct as a child grows ^[9].

The classic facial features of PTHS include:

Bitemporal narrowing: The head appears slightly narrower at the temples ^[8].
Prominent forehead: A squared or forward-sloping forehead ^[5].
Deep-set eyes: The eyes may appear sunken or set back under the brow ^[10].
Distinctive Nose: A broad nasal bridge with a downturned (beaked) tip and flared nostrils ^[8]^[10].
The “M-shaped” Mouth: A wide mouth with a tented or bow-shaped upper lip (shaped like the letter M) and a thick, everted (turned out) lower lip ^[10]^[11].
Widely spaced teeth: Gaps between the teeth are common ^[1].

Differentiating PTHS from “Look-Alike” Syndromes

Because PTHS involves severe intellectual disability, limited speech, and sometimes seizures, it is frequently mistaken for other conditions ^[8]. However, there are key clinical clues that help specialists tell them apart, though molecular testing is what ultimately establishes the diagnosis:

Condition	Primary Gene	Key Overlapping Features
Pitt-Hopkins (PTHS)	TCF4	Awake hyperventilation (fast breathing) followed by apnea (breath-holding); the “M-shaped” upper lip ^[5]^[8].
Angelman Syndrome	UBE3A	Absent speech, epilepsy, developmental delay, and an outwardly cheerful or sociable demeanor ^[12]^[8].
Rett Syndrome	MECP2	Microcephaly, seizures, and severe communication limitations ^[13]^[14].
Mowat-Wilson (MWS)	ZEB2	Severe constipation (including Hirschsprung disease), absent speech, and distinct facial features ^[15]^[16].

The Diagnostic Path

The journey to a PTHS diagnosis usually follows a specific sequence of genetic testing chosen by a clinical geneticist, which may include targeted gene panels, Whole Exome/Genome Sequencing (WES/WGS), or Chromosomal Microarray (CMA) ^[17]^[3]^[18]. A normal microarray does not exclude PTHS.

Once a mutation is found in a child, doctors often test the parents. In most cases, the mutation is de novo, meaning it happened for the first time in the child and was not inherited ^[19]. However, a parent can sometimes have germline mosaicism, where the mutation is present in their eggs or sperm but not in their blood ^[20]. Identifying this with genetic counseling is crucial for understanding the risk of PTHS occurring in future pregnancies ^[21].

Common questions in this guide

What gene causes Pitt-Hopkins syndrome?

Pitt-Hopkins syndrome is caused by a disease-causing change or deletion affecting one copy of the TCF4 gene on chromosome 18. TCF4 helps control other genes involved in brain development, so loss of enough working TCF4 protein can affect development and communication.

How is Pitt-Hopkins syndrome diagnosed?

Diagnosis is established by genetic testing that finds a pathogenic or likely pathogenic change in TCF4, or a deletion that includes the gene. Testing may involve a targeted gene panel, whole-exome or whole-genome sequencing, or a chromosomal microarray; a normal microarray does not rule out Pitt-Hopkins syndrome.

Does a TCF4 variant of uncertain significance confirm PTHS?

No. A variant of uncertain significance, or VUS, does not by itself establish Pitt-Hopkins syndrome. The result should be reviewed with a clinical geneticist, who can interpret it alongside the child’s features and other testing.

Is Pitt-Hopkins syndrome inherited from a parent?

In most children, the TCF4 change is de novo, meaning it happened for the first time in the child and was not inherited. Rarely, a parent may have germline mosaicism, in which the change is present in some eggs or sperm but not detectable in blood; genetic counseling can help estimate the chance in a future pregnancy.

What facial features can suggest Pitt-Hopkins syndrome?

Clinicians may look for a recognizable pattern that includes narrowing at the temples, a prominent forehead, deep-set eyes, a broad nasal bridge with a downturned tip, and an M-shaped upper lip with a full lower lip. These features may become clearer as a child grows, but facial appearance alone cannot confirm the diagnosis; genetic testing is needed.

What breathing pattern is associated with Pitt-Hopkins syndrome?

Some children with Pitt-Hopkins syndrome have episodes of fast breathing while awake followed by pauses or breath-holding called apnea. Families should discuss any unusual breathing episodes with the child’s healthcare team, especially if breathing appears difficult or unsafe.

Can Pitt-Hopkins syndrome be confused with Angelman or Rett syndrome?

Yes. Pitt-Hopkins, Angelman, Rett, and Mowat-Wilson syndromes can share developmental delay, limited speech, seizures, or distinctive facial features. Their associated genes differ, and molecular genetic testing helps distinguish them rather than relying on appearance alone.

Get notified when new evidence is published on Pitt-Hopkins syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (21)

1
Pitt-Hopkins Syndrome: Clinical and Molecular Findings of a 5-Year-Old Patient.
Tripon F, Bogliș A, Micheu C, et al.
Genes 2020; (11(6)) doi:10.3390/genes11060596.
PMID: 32481733
2
Langerhans cell histiocytosis in a young patient with Pitt-Hopkins syndrome.
Macchiaiolo M, Panfili FM, Gonfiantini MV, et al.
American journal of medical genetics. Part A 2020; (182(11)):2746-2750 doi:10.1002/ajmg.a.61840.
PMID: 32945094
3
Pitt-Hopkins Syndrome: A Unique Case Study.
Tan A, Goodspeed K, Edgar VB
Journal of the International Neuropsychological Society : JINS 2018; (24(9)):995-1002 doi:10.1017/S1355617718000668.
PMID: 30375316
4
Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis.
Mary L, Piton A, Schaefer E, et al.
European journal of human genetics : EJHG 2018; (26(7)):996-1006 doi:10.1038/s41431-018-0096-4.
PMID: 29695756
5
Diagnosis and management in Pitt-Hopkins syndrome: First international consensus statement.
Zollino M, Zweier C, Van Balkom ID, et al.
Clinical genetics 2019; (95(4)):462-478 doi:10.1111/cge.13506.
PMID: 30677142
6
Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome.
Sparber P, Filatova A, Anisimova I, et al.
European journal of medical genetics 2020; (63(12)):104088 doi:10.1016/j.ejmg.2020.104088.
PMID: 33069932
7
Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.
Sirp A, Roots K, Nurm K, et al.
The Journal of biological chemistry 2021; (297(6)):101381 doi:10.1016/j.jbc.2021.101381.
PMID: 34748727
8
Pitt-Hopkins Syndrome and Differential Diagnosis: A Molecular and Clinical Challenge.
Marangi G, Zollino M
Journal of pediatric genetics 2015; (4(3)):168-76 doi:10.1055/s-0035-1564570.
PMID: 27617128
9
CDKL5 mutations may mimic Pitt-Hopkins syndrome phenotype.
Currò A, Doddato G, Bruttini M, et al.
European journal of medical genetics 2021; (64(1)):104102 doi:10.1016/j.ejmg.2020.104102.
PMID: 33220470
10
Pitt-Hopkins syndrome: Mental retardation, psychomotor and developmental delays with facial dysmorphism.
Avina Fierro JA, Avina DA
Journal of pediatric genetics 2014; (3(3)):141-5 doi:10.3233/PGE-14094.
PMID: 27625870
11
Expanding the phenotype in Pitt-Hopkins syndrome; description of new oral finding and dental management considerations.
Hassona Y, Alqaisi D, Alkilani A, AbuHijleh I
BMC oral health 2024; (24(1)):597 doi:10.1186/s12903-024-04296-5.
PMID: 38778377
12
Multi-targeting zinc finger nuclease vector unsilences paternal UBE3A in a mouse model of Angelman syndrome.
Bazick HO, James LM, Taylor-Blake B, et al.
Gene therapy 2026; (33(1)):57-67 doi:10.1038/s41434-025-00582-1.
PMID: 41291049
13
Epilepsy in Rett syndrome--lessons from the Rett networked database.
Nissenkorn A, Levy-Drummer RS, Bondi O, et al.
Epilepsia 2015; (56(4)):569-76 doi:10.1111/epi.12941.
PMID: 25789914
14
Autonomic breathing abnormalities in Rett syndrome: caregiver perspectives in an international database study.
Mackay J, Downs J, Wong K, et al.
Journal of neurodevelopmental disorders 2017; (9()):15 doi:10.1186/s11689-017-9196-7.
PMID: 28465761
15
Mowat-Wilson syndrome in a Chinese population: A case series.
Ho S, Luk HM, Chung BH, et al.
American journal of medical genetics. Part A 2020; (182(6)):1336-1341 doi:10.1002/ajmg.a.61557.
PMID: 32196960
16
A Chinese Boy with Mowat-Wilson Syndrome Caused by a 10 bp Deletion in the ZEB2 Gene.
Wei L, Han X, Li X, et al.
Pharmacogenomics and personalized medicine 2021; (14()):1041-1045 doi:10.2147/PGPM.S320128.
PMID: 34466018
17
Pitt-Hopkins syndrome (PTHS)- a case report from Pakistan.
Nasir A, Afroze B, Ilyas S, et al.
JPMA. The Journal of the Pakistan Medical Association 2026; (76(7)):1163-1165 doi:10.47391/JPMA.30215.
PMID: 42444233
18
A novel variant in the 3' UTR of the TCF4 gene likely causes Pitt-Hopkins syndrome: a case report.
Zhao T, Yang F, Zhang B, et al.
Orphanet journal of rare diseases 2024; (19(1)):368 doi:10.1186/s13023-024-03383-8.
PMID: 39375747
19
A case of Pitt-hopkins Syndrome with de novo mutation in TCF4: Clinical features and treatment for epilepsy.
Liu Y, Guo Y, Liu P, et al.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2018; (67()):51-54 doi:10.1016/j.ijdevneu.2018.03.010.
PMID: 29604340
20
Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.
Goodspeed K, Newsom C, Morris MA, et al.
Journal of child neurology 2018; (33(3)):233-244 doi:10.1177/0883073817750490.
PMID: 29318938
21
A typical variant in TCF4 exon 18 is not associated with Pitt-Hopkins syndrome but with a familial case of mild and nonspecific neurodevelopmental disorder.
Aldeeri AA, Abu-El-Haija A
American journal of medical genetics. Part A 2023; (191(4)):1070-1076 doi:10.1002/ajmg.a.63098.
PMID: 36574749

This page explains the genetics and diagnostic clues of Pitt-Hopkins syndrome for informational purposes only and is not medical advice. A clinical geneticist and your child’s healthcare team should interpret genetic results and guide care.